Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

DANSK BIOTRANSPORT A/S Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Bankruptcy risk for industry   5.7% 5.7% 5.7% 5.7% 5.7% 5.7% 5.7% 5.7%   Bankruptcy risk   0.7% 0.7% 0.8% 0.8% 0.5% 0.6% 7.3% 7.1%   Credit score (0-100)   94 96 91 91 98 95 33 34   Credit rating   AA AA AA AA AA AA BBB BBB   Credit limit (kDKK)   1,382.1 1,651.9 1,518.9 1,540.7 2,293.9 1,764.8 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   21,210 23,272 24,476 23,976 29,076 24,956 0.0 0.0   EBITDA   3,832 4,780 4,460 3,920 8,081 3,228 0.0 0.0   EBIT   1,438 2,046 1,922 1,488 5,190 267 0.0 0.0   Pre-tax profit (PTP)   1,696.0 2,193.0 2,167.0 1,557.0 5,005.0 340.8 0.0 0.0   Net earnings   1,329.0 1,742.0 1,714.7 1,238.0 3,856.0 262.5 0.0 0.0   Pre-tax profit without non-rec. items   1,696 2,193 2,167 1,557 5,005 341 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Tangible assets total   7,839 7,688 8,398 7,859 8,856 7,155 0.0 0.0   Shareholders equity total   10,562 11,304 12,019 12,257 14,113 12,376 10,062 10,062   Interest-bearing liabilities   0.0 15.0 0.0 235 0.0 0.0 0.0 0.0   Balance sheet total (assets)   19,830 20,866 23,926 23,189 23,317 20,789 10,062 10,062   Net Debt   -108 -1,424 -1,992 -696 -2,170 -2,071 -10,062 -10,062     See the entire balance sheet 1000.0 Volume  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   21,210 23,272 24,476 23,976 29,076 24,956 0.0 0.0   Gross profit growth   -2.2% 9.7% 5.2% -2.0% 21.3% -14.2% -100.0% 0.0%   Employees   31 33 36 36 37 37 0 0   Employee growth %   0.0% 6.5% 9.1% 0.0% 2.8% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   19,830 20,866 23,926 23,189 23,317 20,789 10,062 10,062   Balance sheet change%   -9.8% 5.2% 14.7% -3.1% 0.6% -10.8% -51.6% 0.0%   Added value   3,832.0 4,780.0 4,460.5 3,920.0 7,622.0 3,227.7 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -2,569 -2,885 -1,828 -2,971 -1,894 -4,662 -7,155 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 4.0 5.0 5.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   6.8% 8.8% 7.9% 6.2% 17.8% 1.1% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   8.2% 10.8% 9.8% 6.9% 21.5% 1.5% 0.0% 0.0%   ROI %   15.2% 19.5% 18.3% 12.9% 36.5% 2.5% 0.0% 0.0%   ROE %   12.8% 15.9% 14.7% 10.2% 29.2% 2.0% 0.0% 0.0%   1000.0 Solidity  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Equity ratio %   53.3% 54.2% 50.2% 52.9% 60.5% 59.5% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -2.8% -29.8% -44.7% -17.8% -26.9% -64.2% 0.0% 0.0%   Gearing %   0.0% 0.1% 0.0% 1.9% 0.0% 0.0% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   3.3% 120.0% 450.2% 57.0% 2.6% 0.0% 0.0% 0.0%   1000.0 Liquidity  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Quick Ratio   1.1 1.2 1.1 1.2 1.4 1.4 0.0 0.0   Current Ratio   1.2 1.2 1.2 1.3 1.5 1.5 0.0 0.0   Cash and cash equivalent   108.0 1,439.0 1,991.7 931.0 2,170.0 2,070.8 0.0 0.0   1000.0 Capital use efficiency  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   1,418.0 2,131.0 2,031.8 2,677.0 4,208.0 4,071.2 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   124 145 124 109 206 87 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   124 145 124 109 218 87 0 0   EBIT / employee   46 62 53 41 140 7 0 0   Net earnings / employee   43 53 48 34 104 7 0 0